Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Japan Inc.

Division of Pfizer Inc.

Latest From Pfizer Japan Inc.

Daiichi Sankyo Launches Amgen's Bevacizumab In Japan

Daiichi Sankyo has introduced Amgen’s bevacizumab biosimilar in Japan, hot on the heels of Pfizer’s launch of its own rival to Avastin in the country.

Launches Biosimilars

Japan Price Reforms Will Be Pro-Innovation, Inclusive - Official

A Japanese official provides reassurances at BIO Asia that the government intends to abide by drug pricing policies that support innovation, although the research-based pharma industry remains concerned that sweeping reforms now under discussion may hamper R&D and investment in the country.

Japan Policy

Lilly Eyes Top 10 Japan Ranking Built On Stream Of Launches

Lilly says it remains on track to enter the pharma industry top 10 in Japan by sales by 2020, driven by planned launches of a raft of new products and despite some major recent losses of exclusivity.

Japan Commercial

Japan Pricing Reform Process Must Be Participative – Pfizer

Against a background of ongoing discussions in Japan over the reform of the drug pricing and reimbursement system, Pfizer is calling for greater industry participation and recognition of the value of innovation.

Japan Reimbursement
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Hiromitsu Iwasaki, Pres. & CEO
  • Contact Info
  • Pfizer Japan Inc.
    Phone: 353097000
    Shinjuku Bunka Quint Building
    Tokyo, 151-8589